Table 3 The association analysis between NSE and SCC
No. (%) | |||||
|---|---|---|---|---|---|
Neg | Moderate | High | Total | P Value | |
(1–2 fold) | >2 fold | ||||
(n = 110) | (n = 70) | (n = 35) | (n = 215) | ||
Basic Characteristics | |||||
Age | |||||
< 45 years | 3 (2.7) | 2 (2.9) | 0 (0.0) | 5 | 0.622 |
45–60 years | 40 (36.4) | 23 (32.8) | 9 (25.7) | 72 | |
> 60 years | 67 (60.9) | 45 (64.3) | 26 (74.3) | 138 | |
Sex | |||||
Male | 101 (91.8) | 61 (87.1) | 30 (85.7) | 192 | 0.463 |
Female | 9 (8.2) | 9 (12.9) | 5 (14.3) | 23 | |
Stages | |||||
I + II | 26 (23.6) | 6 (8.6) | 1 (2.8) | 33 | <0.05* |
III + IV | 80 (72.7) | 62 (88.6) | 33 (94.4) | 175 | |
Unknown | 4 (3.7) | 2 (2.8) | 1 (2.8) | 7 | |
Smoke status | |||||
No | 22 (20.0) | 16 (22.9) | 9 (25.7) | 47 | 0.753 |
Yes | 88 (80.0) | 54 (77.1) | 26 (74.3) | 168 | |
Metastasis | |||||
Brain | |||||
No | 107 (97.3) | 62 (88.6) | 27 (77.1) | 196 | <0.05* |
Yes | 3 (2.7) | 8 (11.4) | 8 (22.9) | 19 | |
Bone | |||||
No | 100 (90.9) | 55 (78.6) | 27 (77.1) | 182 | <0.05* |
Yes | 10 (9.1) | 15 (21.4) | 8 (22.9) | 33 | |
Liver | |||||
No | 102 (92.7) | 61 (87.1) | 27 (77.1) | 190 | 0.062 |
Yes | 8 (7.3) | 9 (12.9) | 8 (22.9) | 25 | |
Adrenal gland | |||||
No | 106 (96.4) | 64 (91.4) | 32 (91.4) | 202 | 0.316 |
Yes | 4 (3.6) | 6 (8.6) | 3 (8.6) | 13 | |
Lymph node | |||||
No | 51 (46.4) | 19 (27.1) | 9 (25.7) | 79 | <0.05* |
Yes | 59 (53.6) | 51 (72.9) | 26 (74.3) | 136 | |
Intrapulmonary | |||||
No | 96 (87.3) | 58 (82.9) | 31 (88.6) | 185 | 0.632 |
Yes | 14 (12.7) | 12 (17.1) | 4 (11.4) | 30 | |
Pleural | |||||
No | 98 (89.1) | 59 (84.3) | 31 (88.6) | 188 | 0.622 |
Yes | 12 (10.9) | 11 (15.7) | 4 (11.4) | 27 | |
Mediastinal | |||||
No | 108 (98.2) | 61 (87.1) | 34 (97.1) | 203 | <0.05* |
Yes | 2 (1.8) | 9 (12.9) | 1 (2.9) | 12 | |
Peritoneum | |||||
No | 109 (99.1) | 61 (87.1) | 31 (88.6) | 201 | <0.05* |
Yes | 1 (0.9) | 9 (12.9) | 4 (11.4) | 14 | |